It is a pharma private limited company based in Andhra Pradesh, Telangana, India, established in 2000.
2000 | Andhra Pradesh, Telangana, India | ActiveStyris Pharma Private Limited, a active private limited company, was established on 03 April 2000 in Andhra Pradesh, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239TG2000PTC034175. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.90 M and a paid-up capital of ₹0.90 M.
Formerly known as Lorven Pharma Private Limited. It upholds a compliant status. Its leadership includes Kodanda Ramu Pilla (Managing Director), Venkata Nalini Pilla (Director). Past directors included Venkata Nalini Pilla, Kanaka Lakshmi Saladi. It holds no open charges and ₹2.13 M settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 1-4-69/2,1St Floor Street No 8Habsiguda Hyderabad, Andhra Pradesh, Telangana, 500007.
U24239TG2000PTC034175
034175
03 April 2000
₹0.90 M
₹0.90 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Styris Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kodanda Ramu Pilla | Managing Director | 03 Apr 2000 | Current |
| Venkata Nalini Pilla | Director | 11 Feb 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 11 Feb 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Styris Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.81% decrease. The company also saw a substantial fall in profitability, with a 11.95% decrease in profit. The company's net worth moved up by a moderate rise of 7.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Styris Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,133,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2008 | City Union Bank Limited | ₹2.00 M | Satisfied |
| 28 Feb 2006 | Sri Lakshmi Vilas Bank Ltd. | ₹0.13 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Styris Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Styris Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styris Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Styris Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Styris Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was recorded as a recent event.
The activity A charge registered on 21 Feb 2008 via Charge ID 10089970 with City Union Bank Limited was fully satisfied on 02 May 2018. was completed.
The activity A charge with City Union Bank Limited of Rs. 2.00 M registered on 21 Feb 2008 with Charge ID 10089970 was modified on 22 Sep 2014. was completed.
Progress on Venkata Nalini Pilla was appointed as a Director was appointed as a Director on 11 Feb 2013 & has been associated with this company since 12 years 10 months . was documented.
Progress on A charge with City Union Bank Limited amounted to Rs. 2.00 M with Charge ID 10089970 was registered on 21 Feb 2008. was documented.
The CIN of Styris Pharma Private Limited is U24239TG2000PTC034175.
Styris Pharma Private Limited is headquartered at 1-4-69/2,1St Floor Street No 8Habsiguda Hyderabad, Andhra Pradesh, Telangana, 500007.
Styris Pharma Private Limited was incorporated on 03 April 2000.
The current directors of Styris Pharma Private Limited are
The primary industry of Styris Pharma Private Limited is Trade.
Styris Pharma Private Limited is unlisted.
The authorized capital of Styris Pharma Private Limited is ₹0.90 M, and the paid-up capital is ₹0.90 M.
The compliance status of Styris Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX